cancer advice guide
Home   |  Contact us



 
 

Cancer Headlines

Dublin - Research and Markets has announced the addition of Hematological Cancer Therapeutics: Pipelines and Competition to their offering.

Blood cancers include leukemia, lymphoma, and multiple myeloma. Collectively, these cancers are the fifth most commonly occurring cancers and the second leading cause of cancer death. Hematological Cancer Therapeutics: Pipelines and Competition provides a realistic assessment of how newly-approved drugs and candidates in development will impact this sector of the cancer treatment field within the next decade.

The report reviews the activities of the leading companies in this arena and provides a market assessment for all companies currently competing in or contemplating entering the field.

The major strides are being made in small specialist companies with a broad range of compounds in Phases I- III. However, the potential exists for large international companies to enter the market as candidates from niche companies reach later stages and prove useful in a broader context of cancer, as very frequently is the case.

 
 

 
 

 
 

 
 

 
 


 
 

 
 

Colorectal Cancer


Colorectal Cancer and Pain Killers

By Lance Winslow

Some evidence from observation and studies seem to indicate that non-steroidal anti-inflammatory drugs can lower the risk of colorectal cancer. Does this mean you should take an aspirin every day to reduce your risk of colorectal cancer or prevent it? Well it could be said that it would help and research seems to point to that fact. Of course it would not have to be aspirin, it could be Motrin, Advil or a host of other such over the counter type drugs.

Are researchers and doctors recommending this? No they will not go so far as to recommend you take them, unless you are perhaps in an extremely high-risk category. However the studies look to be pretty conclusive in fact go so far as to say they you reduce your risk of colorectal cancer by a little over 50%, which is a huge amount if you start to think about something so simple reducing the risks by that wide of a margin. A weekly usage and the number of years taken seemed to be the key. Too much usage can cause intestinal bleeding and that is a horrible side effect; so do not try this. But the study is interesting indeed.

Much research is continuing in the study of colorectal cancer as it kills about 56,000 Americans per year and about 145,000 are diagnosed now every year. The 20-year study was done on over 83,000 women between the ages of 30 and 55. These women who used aspirin only had a 23 percent less likelihood of colorectal cancer as opposed to those who were non-aspirin users.

While the evidence suggests a reduction in the risk of colorectal cancer from such drugs, it is probably not a good strategy to prevent colorectal cancer. You will need to do your own research and ask your doctor about such things, however this is a very interesting finding and something think about.

"Lance Winslow" - If you have innovative thoughts and unique perspectives, come think with Lance; http://www.WorldThinkTank.net/wttbbs

Article Source: http://EzineArticles.com/



DISCLAIMER - Please note that all articles on this web site does not constitute professional advice. All articles are intended to provide a general view of many topical subjects from a variety of sources. We are not responsible for the content or any sponsored links that you may choose to visit from this web site. We suggest you to consult a solicitor and your doctor for advice relevant to you own situation before making any important decisions.  The author is not an expert in any given field. By printing, downloading, or using you agree to our full terms. Below is a summary of some of the terms. If you do not agree to the full terms, do not use the information. We are only publishers of this material, not authors. Information may have errors or be outdated. Some information is from historical sources or represents opinions of the author. It is for research purposes only. The information is "AS IS", "WITH ALL FAULTS". User assumes all risk of use, damage, or injury. You agree that we have no liability for any damages. We are not liable for any consequential, incidental, indirect, or special damages. You indemnify us for claims caused by you.

 

|  © Plan4 Group 2005